Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ. et al.
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: The impact of the addition of rituximab to CHOP chemotherapy.

Ann Oncol 2010;
21: 1046-52

Bibliographische Angaben herunterladen

Aufrufen in: